tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

VIRX Stock Latest News

Viracta Therapeutics announces Nana-val results from stage 1 NAVAL-1 trial
The FlyViracta Therapeutics announces Nana-val results from stage 1 NAVAL-1 trial
4d ago
VIRX
Viracta Therapeutics to Present Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial at the 2024 Annual Congress of The Hematology Society of Taiwan
PremiumPress Releases
Viracta Therapeutics to Present Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial at the 2024 Annual Congress of The Hematology Society of Taiwan
18d ago
VIRX
Viracta Therapeutics CFO Resigns, Interim Successor Appointed
PremiumCompany Announcements
Viracta Therapeutics CFO Resigns, Interim Successor Appointed
30d ago
8K
VIRX
Viracta Therapeutics reports Q4 EPS (35c), consensus (31c)
PremiumThe Fly
Viracta Therapeutics reports Q4 EPS (35c), consensus (31c)
1M ago
VIRX
Viracta Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
PremiumPress Releases
Viracta Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
1M ago
VIRX
Viracta announces completion of second-stage enrollment in NAVAL-1 trial
PremiumThe FlyViracta announces completion of second-stage enrollment in NAVAL-1 trial
2M ago
VIRX
Oppenheimer biotech/healthcare analysts hold analyst/industry conference call
PremiumThe Fly
Oppenheimer biotech/healthcare analysts hold analyst/industry conference call
2M ago
VIRX
Oppenheimer biotech/healthcare analysts hold analyst/industry conference call
PremiumThe Fly
Oppenheimer biotech/healthcare analysts hold analyst/industry conference call
2M ago
VIRX
Oppenheimer biotech/healthcare analysts hold analyst/industry conference call
PremiumThe Fly
Oppenheimer biotech/healthcare analysts hold analyst/industry conference call
2M ago
VIRX
Viracta Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
PremiumPress Releases
Viracta Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
2M ago
VIRX
Viracta Therapeutics price target lowered to $4 from $10 at H.C. Wainwright
PremiumThe Fly
Viracta Therapeutics price target lowered to $4 from $10 at H.C. Wainwright
4M ago
VIRX
Viracta Therapeutics provides anticipated 2024 milestones
PremiumThe Fly
Viracta Therapeutics provides anticipated 2024 milestones
4M ago
VIRX
Viracta Therapeutics Provides Clinical Update and Outlook for 2024
PremiumPress ReleasesViracta Therapeutics Provides Clinical Update and Outlook for 2024
4M ago
VIRX
Viracta Therapeutics announces ODD granted by U.S. FDA to nana-val
PremiumThe Fly
Viracta Therapeutics announces ODD granted by U.S. FDA to nana-val
4M ago
VIRX
Viracta Therapeutics granted orphan status for carcinoma treatment
PremiumThe Fly
Viracta Therapeutics granted orphan status for carcinoma treatment
4M ago
VIRX
Viracta Therapeutics Announces Interim Data from Phase 1b/2 Clinical Trial of Nana-val in Patients with Epstein-Barr Virus-Positive Solid Tumors that Show Confirmed Tumor Responses at Higher Dose Levels
PremiumPress Releases
Viracta Therapeutics Announces Interim Data from Phase 1b/2 Clinical Trial of Nana-val in Patients with Epstein-Barr Virus-Positive Solid Tumors that Show Confirmed Tumor Responses at Higher Dose Levels
5M ago
VIRX
Viracta Therapeutics announces interim data from Phase 1b/2 trial of nana-val
PremiumThe Fly
Viracta Therapeutics announces interim data from Phase 1b/2 trial of nana-val
5M ago
VIRX
Viracta Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
PremiumPress Releases
Viracta Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
5M ago
VIRX
Viracta Therapeutics reports Q3 EPS (33c), consensus (30c)
PremiumThe Fly
Viracta Therapeutics reports Q3 EPS (33c), consensus (30c)
5M ago
VIRX
Viracta Therapeutics to Present at Upcoming Investor Conferences
PremiumPress ReleasesViracta Therapeutics to Present at Upcoming Investor Conferences
5M ago
VIRX
Viracta Therapeutics, Inc. (VIRX) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Viracta Therapeutics, Inc. (VIRX) Q3 Earnings Cheat Sheet
5M ago
VIRX
Viracta Therapeutics to host R&D Day highlighting Nana-val
PremiumThe Fly
Viracta Therapeutics to host R&D Day highlighting Nana-val
7M ago
VIRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >